Insight

María Natalia Gandur Quiroga: Mutations and DNA Structures Driving Bladder Cancer

María Natalia Gandur Quiroga/X

Oct 11, 2024, 19:37

María Natalia Gandur Quiroga: Mutations and DNA Structures Driving Bladder Cancer

María Natalia Gandur Quiroga recently shared a post on LinkedIn:

“Study Uncovers Mutations and DNA Structures Driving Bladder Cancer.

New mutations and DNA structures drive bladder cancer, according to a study from Weill Cornell Medicine and the New York Genome Center.
APOBEC3 antiviral enzymes mutate DNA, triggering early-stage bladder cancer.
Cisplatin chemotherapy causes bursts of mutations, helping cancer cells resist treatment.
Extrachromosomal circular DNA (ecDNA) promotes therapy resistance in bladder cancer.
This study highlights new therapeutic strategies for a hard-to-treat cancer.”

APOBEC3 bladder cancer cancer Cisplatin DNA Structures María Natalia Gandur Quiroga mutations New York Genome Center OncoDaily Oncology Weill Cornell Medicine

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage